Beacon Capital Management, LLC - EVAXION BIOTECH A S ownership

Back to all holdings Add to watchlist

EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 11 filers reported holding EVAXION BIOTECH A S in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Beacon Capital Management, LLC ownership history of EVAXION BIOTECH A S
ValueSharesWeighting
Q3 2023$9,0140.0%6,8810.0%0.00%0.0%
Q2 2023$9,014
+15.9%
6,8810.0%0.00%0.0%
Q1 2023$7,776
-36.3%
6,8810.0%0.00%
-50.0%
Q4 2022$12,214–6,881–0.00%–
 Download
Other shareholders
EVAXION BIOTECH A S shareholders Q3 2023
NameSharesValueWeighting ↓
Beacon Capital Management, LLC 6,881$9,0140.00%
Moloney Securities Asset Management, LLC 11,000$9,1630.00%
GROUP ONE TRADING, L.P. 386$3320.00%
MORGAN STANLEY 3,446$2,8710.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,000$9,4600.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 32,774$28,1860.00%
TWO SIGMA SECURITIES, LLC 15,188$12,6520.00%
AE Wealth Management LLC 48,633$40,5110.00%
JPMORGAN CHASE & CO 9,283$7,9830.00%
UBS Group AG 4,005$3,3360.00%
View complete list of EVAXION BIOTECH A S shareholders